Quince Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Quince Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Quince Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.12M, a 15.6% decline year-over-year.
  • Quince Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $809K, a 82.2% decline year-over-year.
  • Quince Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $100K, a 99.4% decline from 2022.
  • Quince Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $16.6M, a 44.3% decline from 2021.
  • Quince Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $29.9M, a 106% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $100K -$16.5M -99.4% Jan 1, 2023 Dec 31, 2023 10-Q 2024-11-13
2022 $16.6M -$13.2M -44.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $29.9M +$15.4M +106% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $14.5M +$12.4M +604% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $2.06M +$1.9M +1226% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $155K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.